Molecular profiling of intestinal cancers: Towards clinical implementation

Gastrointestinal (GI) cancers are molecularly heterogeneous, resulting in pronounced intertumoral differences in disease progression and treatment response. The diversity of GI malignancies complicates estimation of prognosis and optimal timing and selection of treatment regimens for individual patients. In recent years, it has become clear that gene expression (transcriptomic)